Search Results - Lunde, Michelle L

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    FYN and ABL Regulate the Interaction Networks of the DCBLD Receptor Family

    FYN and ABL Regulate the Interaction Networks of the DCBLD Receptor Family by Schmoker, Anna M., Weinert, Jaye L., Markwood, Jacob M., Albretsen, Kathryn S., Lunde, Michelle L., Weir, Marion E., Ebert, Alicia M., Hinkle, Karen L., Ballif, Bryan A.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    FYN and ABL Regulate the Interaction Networks of the DCBLD Receptor Family

    FYN and ABL Regulate the Interaction Networks of the DCBLD Receptor Family by Schmoker, Anna M, Weinert, Jaye L, Markwood, Jacob M, Albretsen, Kathryn S, Lunde, Michelle L, Weir, Marion E, Ebert, Alicia M, Hinkle, Karen L, Ballif, Bryan A

    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    A phase 2 trial of lenalidomide, bortezomib, and dexamethasone in patients with relapsed and relapsed/refractory myeloma

    A phase 2 trial of lenalidomide, bortezomib, and dexamethasone in patients with relapsed and relapsed/refractory myeloma by Richardson, Paul G., Xie, Wanling, Jagannath, Sundar, Jakubowiak, Andrzej, Lonial, Sagar, Raje, Noopur S., Alsina, Melissa, Ghobrial, Irene M., Schlossman, Robert L., Munshi, Nikhil C., Mazumder, Amitabha, Vesole, David H., Kaufman, Jonathan L., Colson, Kathleen, McKenney, Mary, Lunde, Laura E., Feather, John, Maglio, Michelle E., Warren, Diane, Francis, Dixil, Hideshima, Teru, Knight, Robert, Esseltine, Dixie-Lee, Mitsiades, Constantine S., Weller, Edie, Anderson, Kenneth C.

    Published in Blood
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    A Phase 1 Trial of Lenalidomide (REVLIMID®) with Bortezomib (VELCADE®) in Relapsed and Refractory Multiple Myeloma

    A Phase 1 Trial of Lenalidomide (REVLIMID®) with Bortezomib (VELCADE®) in Relapsed and Refractory Multiple Myeloma by Richardson, Paul, Schlossman, R., Munshi, N., Avigan, D., Jagannath, S., Alsina, M., Doss, D., McKenney, M., Hande, K., Farrell, M., Gorelik, S., Colson, K., Warren, D., Lunde, L., Michelle, R., Cole, G., Mitsiades, C., Hideshima, T., Myers, T., Knight, R., Anderson, K.

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Phase I Clinical Trial of Oral Administration of the Histone Deacetylase (HDAC) Inhibitor Suberoylanilide Hydroxamic Acid (SAHA) in Patients with Relapsed/Refractory Multiple Myeloma (MM)

    Phase I Clinical Trial of Oral Administration of the Histone Deacetylase (HDAC) Inhibitor Suberoylanilide Hydroxamic Acid (SAHA) in Patients with Relapsed/Refractory Multiple Myelo... by Richardson, Paul, Schlossman, Robert L., Mitsiades, Constantine S., Munshi, Nikhil C., Colson, Kathleen, Doss, Deborah, McKenney, Mary, Hande, Karen, Gorelik, Svetlana, Lunde, Laura, Stepanek, Anna, Freeman, Andrea, Dinand, Karyn, Hayes, Stephen, Michelle, Reggie, Doucet, Keith, Warren, Diane, Mitsiades, Nicholas, Richon, Victoria M., Chiao, Judi, Anderson, Kenneth C.

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: